Index
1 Metolazone Market Overview
1.1 Product Overview and Scope of Metolazone
1.2 Metolazone Segment by Type
1.2.1 Global Metolazone Sales Growth Rate Comparison by Type (2021-2027)
1.2.2 2.5mg
1.2.3 5mg
1.2.4 10mg
1.3 Metolazone Segment by Application
1.3.1 Metolazone Sales Comparison by Application: (2021-2027)
1.3.2 Edema
1.3.3 Mild Hypertension
1.3.4 Moderate Hypertension
1.4 Global Metolazone Market Size Estimates and Forecasts
1.4.1 Global Metolazone Revenue 2016-2027
1.4.2 Global Metolazone Sales 2016-2027
1.4.3 Metolazone Market Size by Region: 2016 Versus 2021 Versus 2027
2 Metolazone Market Competition by Manufacturers
2.1 Global Metolazone Sales Market Share by Manufacturers (2016-2021)
2.2 Global Metolazone Revenue Market Share by Manufacturers (2016-2021)
2.3 Global Metolazone Average Price by Manufacturers (2016-2021)
2.4 Manufacturers Metolazone Manufacturing Sites, Area Served, Product Type
2.5 Metolazone Market Competitive Situation and Trends
2.5.1 Metolazone Market Concentration Rate
2.5.2 The Global Top 5 and Top 10 Largest Metolazone Players Market Share by Revenue
2.5.3 Global Metolazone Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
2.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Metolazone Retrospective Market Scenario by Region
3.1 Global Metolazone Retrospective Market Scenario in Revenue by Region: 2016-2021
3.2 Global Metolazone Retrospective Market Scenario in Sales by Region: 2016-2021
3.3 North America Metolazone Market Facts & Figures by Country
3.3.1 North America Metolazone Sales by Country
3.3.2 North America Metolazone Revenue by Country
3.3.3 U.S.
3.3.4 Canada
3.4 Europe Metolazone Market Facts & Figures by Country
3.4.1 Europe Metolazone Sales by Country
3.4.2 Europe Metolazone Revenue by Country
3.4.3 Germany
3.4.4 France
3.4.5 U.K.
3.4.6 Italy
3.4.7 Russia
3.5 Asia Pacific Metolazone Market Facts & Figures by Region
3.5.1 Asia Pacific Metolazone Sales by Region
3.5.2 Asia Pacific Metolazone Revenue by Region
3.5.3 China
3.5.4 Japan
3.5.5 South Korea
3.5.6 India
3.5.7 Australia
3.5.8 Taiwan
3.5.9 Indonesia
3.5.10 Thailand
3.5.11 Malaysia
3.5.12 Philippines
3.5.13 Vietnam
3.6 Latin America Metolazone Market Facts & Figures by Country
3.6.1 Latin America Metolazone Sales by Country
3.6.2 Latin America Metolazone Revenue by Country
3.6.3 Mexico
3.6.4 Brazil
3.6.5 Argentina
3.7 Middle East and Africa Metolazone Market Facts & Figures by Country
3.7.1 Middle East and Africa Metolazone Sales by Country
3.7.2 Middle East and Africa Metolazone Revenue by Country
3.7.3 Turkey
3.7.4 Saudi Arabia
3.7.5 UAE
4 Global Metolazone Historic Market Analysis by Type
4.1 Global Metolazone Sales Market Share by Type (2016-2021)
4.2 Global Metolazone Revenue Market Share by Type (2016-2021)
4.3 Global Metolazone Price by Type (2016-2021)
5 Global Metolazone Historic Market Analysis by Application
5.1 Global Metolazone Sales Market Share by Application (2016-2021)
5.2 Global Metolazone Revenue Market Share by Application (2016-2021)
5.3 Global Metolazone Price by Application (2016-2021)
6 Key Companies Profiled
6.1 Mylan
6.1.1 Mylan Corporation Information
6.1.2 Mylan Description and Business Overview
6.1.3 Mylan Metolazone Sales, Revenue and Gross Margin (2016-2021)
6.1.4 Mylan Product Portfolio
6.1.5 Mylan Recent Developments/Updates
6.2 Novartis
6.2.1 Novartis Corporation Information
6.2.2 Novartis Description and Business Overview
6.2.3 Novartis Metolazone Sales, Revenue and Gross Margin (2016-2021)
6.2.4 Novartis Product Portfolio
6.2.5 Novartis Recent Developments/Updates
6.3 Lannett
6.3.1 Lannett Corporation Information
6.3.2 Lannett Description and Business Overview
6.3.3 Lannett Metolazone Sales, Revenue and Gross Margin (2016-2021)
6.3.4 Lannett Product Portfolio
6.3.5 Lannett Recent Developments/Updates
6.4 Gd Searle
6.4.1 Gd Searle Corporation Information
6.4.2 Gd Searle Description and Business Overview
6.4.3 Gd Searle Metolazone Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Gd Searle Product Portfolio
6.4.5 Gd Searle Recent Developments/Updates
6.5 Mylan Pharmaceuticals
6.5.1 Mylan Pharmaceuticals Corporation Information
6.5.2 Mylan Pharmaceuticals Description and Business Overview
6.5.3 Mylan Pharmaceuticals Metolazone Sales, Revenue and Gross Margin (2016-2021)
6.5.4 Mylan Pharmaceuticals Product Portfolio
6.5.5 Mylan Pharmaceuticals Recent Developments/Updates
6.6 Roxane Laboratories
6.6.1 Roxane Laboratories Corporation Information
6.6.2 Roxane Laboratories Description and Business Overview
6.6.3 Roxane Laboratories Metolazone Sales, Revenue and Gross Margin (2016-2021)
6.6.4 Roxane Laboratories Product Portfolio
6.6.5 Roxane Laboratories Recent Developments/Updates
6.7 Teva Pharmaceuticals
6.6.1 Teva Pharmaceuticals Corporation Information
6.6.2 Teva Pharmaceuticals Description and Business Overview
6.6.3 Teva Pharmaceuticals Metolazone Sales, Revenue and Gross Margin (2016-2021)
6.4.4 Teva Pharmaceuticals Product Portfolio
6.7.5 Teva Pharmaceuticals Recent Developments/Updates
6.8 Watson Laboratories
6.8.1 Watson Laboratories Corporation Information
6.8.2 Watson Laboratories Description and Business Overview
6.8.3 Watson Laboratories Metolazone Sales, Revenue and Gross Margin (2016-2021)
6.8.4 Watson Laboratories Product Portfolio
6.8.5 Watson Laboratories Recent Developments/Updates
6.9 UCB
6.9.1 UCB Corporation Information
6.9.2 UCB Description and Business Overview
6.9.3 UCB Metolazone Sales, Revenue and Gross Margin (2016-2021)
6.9.4 UCB Product Portfolio
6.9.5 UCB Recent Developments/Updates
7 Metolazone Manufacturing Cost Analysis
7.1 Metolazone Key Raw Materials Analysis
7.1.1 Key Raw Materials
7.1.2 Key Suppliers of Raw Materials
7.2 Proportion of Manufacturing Cost Structure
7.3 Manufacturing Process Analysis of Metolazone
7.4 Metolazone Industrial Chain Analysis
8 Marketing Channel, Distributors and Customers
8.1 Marketing Channel
8.2 Metolazone Distributors List
8.3 Metolazone Customers
9 Metolazone Market Dynamics
9.1 Metolazone Industry Trends
9.2 Metolazone Growth Drivers
9.3 Metolazone Market Challenges
9.4 Metolazone Market Restraints
10 Global Market Forecast
10.1 Metolazone Market Estimates and Projections by Type
10.1.1 Global Forecasted Sales of Metolazone by Type (2022-2027)
10.1.2 Global Forecasted Revenue of Metolazone by Type (2022-2027)
10.2 Metolazone Market Estimates and Projections by Application
10.2.1 Global Forecasted Sales of Metolazone by Application (2022-2027)
10.2.2 Global Forecasted Revenue of Metolazone by Application (2022-2027)
10.3 Metolazone Market Estimates and Projections by Region
10.3.1 Global Forecasted Sales of Metolazone by Region (2022-2027)
10.3.2 Global Forecasted Revenue of Metolazone by Region (2022-2027)
11 Research Finding and Conclusion
12 Methodology and Data Source
12.1 Methodology/Research Approach
12.1.1 Research Programs/Design
12.1.2 Market Size Estimation
12.1.3 Market Breakdown and Data Triangulation
12.2 Data Source
12.2.1 Secondary Sources
12.2.2 Primary Sources
12.3 Author List
12.4 Disclaimer
List of Tables
List of Tables
Table 1. Global Metolazone Sales (K Units) Growth Rate Comparison by Type (2021-2027)
Table 2. Global Metolazone Sales (K Units) Comparison by Application (2021-2027)
Table 3. Global Metolazone Market Size by Region (US$ Million) (2016 VS 2021 VS 2027)
Table 4. Key Manufacturers Metolazone Covered in This Study
Table 5. Global Metolazone Sales (K Units) of Key Manufacturers (2016-2021)
Table 6. Global Metolazone Sales Share by Manufacturers (2016-2021)
Table 7. Global Metolazone Revenue (US$ Million) by Manufacturers (2016-2021)
Table 8. Global Metolazone Revenue Share by Manufacturers (2016-2021)
Table 9. Global Market Metolazone Average Price (US$/Unit) of Key Manufacturers (2016-2021)
Table 10. Manufacturers Metolazone Manufacturing Sites and Area Served
Table 11. Manufacturers Metolazone Product Type
Table 12. Global Metolazone Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 13. Global Metolazone by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Metolazone as of 2020)
Table 14. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 15. Global Metolazone Sales by Region (2016-2021) & (K Units)
Table 16. Global Metolazone Sales Market Share by Region (2016-2021)
Table 17. Global Metolazone Revenue by Region (2016-2021) & (US$ Million)
Table 18. North America Metolazone Sales by Country (2016-2021) & (K Units)
Table 19. North America Metolazone Sales Market Share by Country (2016-2021)
Table 20. North America Metolazone Revenue by Country (2016-2021) & (US$ Million)
Table 21. North America Metolazone Revenue Market Share by Country (2016-2021)
Table 22. Europe Metolazone Sales by Country (2016-2021) & (K Units)
Table 23. Europe Metolazone Sales Market Share by Country (2016-2021)
Table 24. Europe Metolazone Revenue by Country (2016-2021) & (US$ Million)
Table 25. Europe Metolazone Revenue Market Share by Country (2016-2021)
Table 26. Asia Pacific Metolazone Sales by Region (2016-2021) & (K Units)
Table 27. Asia Pacific Metolazone Sales Market Share by Region (2016-2021)
Table 28. Asia Pacific Metolazone Revenue by Region (2016-2021) & (US$ Million)
Table 29. Asia Pacific Metolazone Revenue Market Share by Region (2016-2021)
Table 30. Latin America Metolazone Sales by Country (2016-2021) & (K Units)
Table 31. Latin America Metolazone Sales Market Share by Country (2016-2021)
Table 32. Latin America Metolazone Revenue by Country (2016-2021) & (US$ Million)
Table 33. Latin America Metolazone Revenue Market Share by Country (2016-2021)
Table 34. Middle East and Africa Metolazone Sales by Country (2016-2021) & (K Units)
Table 35. Middle East and Africa Metolazone Sales Market Share by Country (2016-2021)
Table 36. Middle East and Africa Metolazone Revenue by Country (2016-2021) & (US$ Million)
Table 37. Middle East and Africa Metolazone Revenue Market Share by Country (2016-2021)
Table 38. Global Metolazone Sales (K Units) by Type (2016-2021)
Table 39. Global Metolazone Sales Market Share by Type (2016-2021)
Table 40. Global Metolazone Revenue (Million US$) by Type (2016-2021)
Table 41. Global Metolazone Revenue Share by Type (2016-2021)
Table 42. Global Metolazone Price (US$/Unit) by Type (2016-2021)
Table 43. Global Metolazone Sales (K Units) by Application (2016-2021)
Table 44. Global Metolazone Sales Market Share by Application (2016-2021)
Table 45. Global Metolazone Revenue (Million US$) by Application (2016-2021)
Table 46. Global Metolazone Revenue Share by Application (2016-2021)
Table 47. Global Metolazone Price (US$/Unit) by Application (2016-2021)
Table 48. Mylan Corporation Information
Table 49. Mylan Description and Business Overview
Table 50. Mylan Metolazone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 51. Mylan Metolazone Product
Table 52. Mylan Recent Developments/Updates
Table 53. Novartis Corporation Information
Table 54. Novartis Description and Business Overview
Table 55. Novartis Metolazone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 56. Novartis Metolazone Product
Table 57. Novartis Recent Developments/Updates
Table 58. Lannett Corporation Information
Table 59. Lannett Description and Business Overview
Table 60. Lannett Metolazone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 61. Lannett Metolazone Product
Table 62. Lannett Recent Developments/Updates
Table 63. Gd Searle Corporation Information
Table 64. Gd Searle Description and Business Overview
Table 65. Gd Searle Metolazone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 66. Gd Searle Metolazone Product
Table 67. Gd Searle Recent Developments/Updates
Table 68. Mylan Pharmaceuticals Corporation Information
Table 69. Mylan Pharmaceuticals Description and Business Overview
Table 70. Mylan Pharmaceuticals Metolazone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 71. Mylan Pharmaceuticals Metolazone Product
Table 72. Mylan Pharmaceuticals Recent Developments/Updates
Table 73. Roxane Laboratories Corporation Information
Table 74. Roxane Laboratories Description and Business Overview
Table 75. Roxane Laboratories Metolazone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 76. Roxane Laboratories Metolazone Product
Table 77. Roxane Laboratories Recent Developments/Updates
Table 78. Teva Pharmaceuticals Corporation Information
Table 79. Teva Pharmaceuticals Description and Business Overview
Table 80. Teva Pharmaceuticals Metolazone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 81. Teva Pharmaceuticals Metolazone Product
Table 82. Teva Pharmaceuticals Recent Developments/Updates
Table 83. Watson Laboratories Corporation Information
Table 84. Watson Laboratories Description and Business Overview
Table 85. Watson Laboratories Metolazone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 86. Watson Laboratories Metolazone Product
Table 87. Watson Laboratories Recent Developments/Updates
Table 88. UCB Corporation Information
Table 89. UCB Description and Business Overview
Table 90. UCB Metolazone Sales (K Units), Revenue (Million US$), Price (US$/Unit) and Gross Margin (2016-2021)
Table 91. UCB Metolazone Product
Table 92. UCB Recent Developments/Updates
Table 93. Production Base and Market Concentration Rate of Raw Material
Table 94. Key Suppliers of Raw Materials
Table 95. Metolazone Distributors List
Table 96. Metolazone Customers List
Table 97. Metolazone Market Trends
Table 98. Metolazone Growth Drivers
Table 99. Metolazone Market Restraints
Table 100. Global Metolazone Sales Forecast by Type (2022-2027) & (K Units)
Table 101. Global Metolazone Sales Market Share Forecast by Type (2022-2027)
Table 102. Global Metolazone Revenue Forecast by Type (2022-2027) & (US$ Million)
Table 103. Global Metolazone Revenue Market Share Forecast by Type (2022-2027)
Table 104. Global Metolazone Sales Forecast by Application (2022-2027) & (K Units)
Table 105. Global Metolazone Sales Market Share Forecast by Application (2022-2027)
Table 106. Global Metolazone Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 107. Global Metolazone Revenue Market Share Forecast by Application (2022-2027)
Table 108. Global Metolazone Sales Forecast by Region (2022-2027) & (K Units)
Table 109. Global Metolazone Sales Market Share Forecast by Region (2022-2027)
Table 110. Global Metolazone Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 111. Global Metolazone Revenue Market Share Forecast by Region (2022-2027)
Table 112. Research Programs/Design for This Report
Table 113. Key Data Information from Secondary Sources
Table 114. Key Data Information from Primary Sources
List of Figures
Figure 1. Product Picture of Metolazone
Figure 2. Global Metolazone Market Share by Type in 2020 & 2027
Figure 3. 2.5mg Product Picture
Figure 4. 5mg Product Picture
Figure 5. 10mg Product Picture
Figure 6. Global Metolazone Market Share by Application in 2020 & 2027
Figure 7. Edema
Figure 8. Mild Hypertension
Figure 9. Moderate Hypertension
Figure 10. Global Metolazone Revenue, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global Metolazone Market Size 2016-2027 (US$ Million)
Figure 12. Global Metolazone Sales 2016-2027 (K Units)
Figure 13. Global Metolazone Market Size Market Share by Region: 2016 VS 20210 VS 2027
Figure 14. Metolazone Sales Share by Manufacturers in 2020
Figure 15. Global Metolazone Revenue Share by Manufacturers in 2020
Figure 16. The Global 5 and 10 Largest Metolazone Players: Market Share by Revenue in 2020
Figure 17. Metolazone Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2021
Figure 18. Global Metolazone Sales Market Share by Region (2016-2021)
Figure 19. Global Metolazone Sales Market Share by Region in 2020
Figure 20. Global Metolazone Revenue Market Share by Region (2016-2021)
Figure 21. Global Metolazone Revenue Market Share by Region in 2020
Figure 22. U.S. Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 23. Canada Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 24. Germany Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 25. France Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 26. U.K. Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 27. Italy Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 28. Russia Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 29. China Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 30. Japan Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 31. South Korea Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 32. India Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 33. Australia Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 34. Taiwan Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 35. Indonesia Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 36. Thailand Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 37. Malaysia Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 38. Philippines Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 39. Vietnam Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 40. Mexico Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 41. Brazil Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 42. Argentina Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Turkey Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 44. Saudi Arabia Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. UAE Metolazone Revenue Growth Rate (2016-2021) (US$ Million)
Figure 46. Sales Market Share of Metolazone by Type (2016-2021)
Figure 47. Sales Market Share of Metolazone by Application (2016-2021)
Figure 48. Sales Market Share of Metolazone by Application in 2020
Figure 49. Revenue Share of Metolazone by Application (2016-2021)
Figure 50. Revenue Share of Metolazone by Application in 2020
Figure 51. Manufacturing Cost Structure of Metolazone
Figure 52. Manufacturing Process Analysis of Metolazone
Figure 53. Metolazone Industrial Chain Analysis
Figure 54. Channels of Distribution
Figure 55. Distributors Profiles
Figure 56. Bottom-up and Top-down Approaches for This Report
Figure 57. Data Triangulation
Figure 58. Key Executives Interviewed